(Q62810695)

English

Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Phase II Study, Randomized, Double-Blind, Placebo-Controlled 4-Week Clinical Study, to Evaluate the Efficacy and Safety of MK-7264 in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (English)

0 references

0 references

0 references

0 references

16 March 2018

0 references

end time

7 June 2018

0 references

number of participants

23

0 references

clinical trial phase

phase II clinical trial

0 references

research subject recruitment status

completed

0 references

minimum age

20 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03482713

0 references

(Q62810695)

Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)